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Background: Dyslipidemia is a key independent modifiable risk factor for Cardiovascular Disease, which is a leading
contributor to morbidity and mortality in most developed and developing countries. This study was designed to
investigate the current epidemiological features of dyslipidemia among adults in rural China.
Methods: Between January 2013 and August 2013, we conducted a cross-sectional study involving 11,956 subjects
with age ≥35 years in a general Chinese population. Permanent residents of the population were invited to participate
in the study and the response rate was at 85.3%. Dyslipidemia was identified based on serum lipids levels following the
standards proposed by the National Cholesterol Education Program Adult Treatment Panel III. Multivariate logistic
regression analysis was used to evaluate the associated risk factors for dyslipidemia.
Results: Within the study population, 16.4% had high TC, 13.8% had low HDL-C, 7.6% had high LDL-C, and 17.3%
had high TG concentrations. Prevalence of lipid abnormality (including borderline dyslipidemia and dyslipidemia)
was 47.8%, 13.8%, 25.7% and 30.7% for TC, HDL-C, LDL-C and TG, respectively. Detailed analysis indicated that
36.9% of this population had at least one type of dyslipidemia and 64.4% had at least one type of abnormal lipid
concentration. Thus, this study observed an alarmingly higher prevalence of lipid abnormality, in a relatively large
population, compared to previous studies. Further, we determined that not all of the risk factors studied, including age,
gender, hypertension, diabetes mellitus, obesity, smoking, drinking, education level, marital status, and family income,
influenced dyslipidemia to the same extent.
Conclusions: Our present study, in a population of 11,956 adults in Liaoning Providence, demonstrated a very high
prevalence of dyslipidemia, which represented an alarming rise since the publication of our previous study and other
similar studies around the world, which report lower levels. We also examined various risk factors for dyslipidemia,
many of which are modifiable risk factors for Cardiovascular Disease (CVD), to provide a comprehensive view that will
help in designing strategies to slow the rapid spread and promote effective measures to treat dyslipidemia. Our
ultimate goal is to prevent the increasing prevalence of lipid abnormality and reduce the burden of CVD in rural China.
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Cardiovascular Disease (CVD) is a major cause of mor-
bidity and a leading contributor to mortality in both
developed and developing countries [1]. With rapid so-
cioeconomic development, CVD has reached epidemic
proportions in developing countries in recent decades
[2-4]. China is a developing country, and has a high level
of CVD mortality, accounting for nearly 40 percent of all
deaths. Furthermore, CVD morbidity and mortality in* Correspondence: sunyingxian84@yeah.net
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unless otherwise stated.China has been projected to increase substantially both in
absolute numbers and as a proportion of total disease bur-
den in the population over the next 20 years [5].
Dyslipidemia is an important modifiable risk factor for
the development of atherosclerosis and CVD [6-8]. Effect-
ive management of dyslipidemia, by pharmacological
treatment or lifestyle changes, is known to reduce the
rate of CVD morbidity and mortality [9-11]. In the
United States, the National Health and Nutrition Examin-
ation Survey (NHANES) 2003–2006 showed that 52.9% of
adults had lipid abnormalities (including borderline dys-
lipidemia and dyslipidemia) [12]. In China, the prevalenceis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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cording to the Chinese National Nutrition and Health
Survey in 2002 [13]. The results from the International
Collaborative Study of Cardiovascular Disease in Asia
(InterAsia), conducted during 2000 to 2001, demonstrated
that the prevalence in Chinese adults was 53.6% (aged 35-
74 years) when borderline dyslipidemia and dyslipidemia
numbers are combined [14]. With rapid economic growth
and associated lifestyle changes, dyslipidemia in China has
increased significantly during the past decade [15-17].
Paradoxically, surveys to monitor and measure dyslip-
idemia burden in a Chinese population has not been
conducted in recent years and the available data on the
prevalence, types, and associated factors of dyslipidemia
in the general population is relatively insufficient and
outdated. Therefore, the objective of this study was to
obtain current data on dyslipidemia.
Materials and methods
Study population
Liaoning Province is located in northeast China. Between
January 2013 to August 2013, a representative sample
aged ≥35 years was selected to study the prevalence and
natural history of cardiovascular risk factors in the coun-
tryside of Liaoning Province. The study adopted a multi-
stage, stratified, randomly cluster-sampling scheme. In the
first stage, 3 counties (Dawa, Zhangwu, and Liaoyang)
were selected from the eastern, southern, and northern re-
gion of Liaoning province. In the second stage, one town
near the city was randomly selected from each county (a
total of 3 towns). In the third stage, 6-8 villages from each
town were randomly selected (a total of 26 rural villages).
Pregnant participants, those with malignant tumors, and
those with mental disorders were excluded. All eligible
permanent residents aged ≥35 years from each village
were invited to attend the study (a total of 14016 partici-
pants). Of those, 11956 participants agreed and completed
the study giving a response rate of 85.3%. The study
was approved by the Ethics Committee of China Medical
University (Shenyang, China). All procedures were per-
formed in accordance with ethical standards. Written con-
sent was obtained from all participants after they had
been informed of the objectives, benefits, medical items,
and confidentiality agreement of personal information. If
the participants were illiterate, we obtained the written in-
formed consents from their proxies.
Data collection and measurements
Before the survey began, all investigators attended orga-
nized training sessions. The training contents included
the purpose of this study, how to properly administer
the questionnaire, the standard method of measurement,
the importance of standardization, and the study proce-
dures. A strict test was administered to evaluate theeffectiveness of the training, and only those who scored
correct on all test questions could become eligible inves-
tigators. During data collection, our inspectors received
further instructions and support.
Data was collected during a single clinic visit with cardi-
ologists and trained nurses using a standard questionnaire
in face-to-face interviews. Data on demographic charac-
teristics, medical history of hypertension and diabetes
mellitus, lifestyle risk factors, educational level, marital
status, and family income were obtained by interview
with a standardized questionnaire. Organizationally, we
adapted a central steering committee with a subcom-
mittee for quality control.
According to American Heart Association protocol,
blood pressure (BP) was measured three times at 2-min
intervals after at least 5 min of rest using a standard-
ized automatic electronic sphygmomanometer (HEM-
907; Omron). The calibration of the Omron device was
checked prior to use, using a standard mercury sphyg-
momanometer every month by two doctors according
to the British Hypertension Society protocol [18]. The
participants were advised to avoid caffeinated beverages
and exercise for at least 30 min prior to the measure-
ment. During the measurement, the participants were
seated with the arm supported at heart level. The mean
of three BP measures was calculated and used in all
analyses.
Weight and height were measured to the nearest 0.1
kg and 0.1 cm, respectively, with the participants in
light-weight clothing and without shoes. Waist circum-
ference was measured at the umbilicus to the nearest 0.1
cm [19], with the participants standing and at the end of
normal expiration. The body mass index (BMI) was cal-
culated as weight in kilograms divided by the square of
the height in meters.
Fasting blood samples were collected in the morning
after at least 8h of fasting for all participants. Blood
samples were obtained from an antecubital vein into
Vacutainer tubes containing EDTA. Serum was subse-
quently isolated from the blood, and all serum samples
were frozen at –20°C for testing at a central, certified
laboratory. Fasting plasma glucose (FPG), total cholesterol,
low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), triglycerides, and other
routine blood biochemical indexes were analyzed enzy-
matically on an Olympus AU640 autoanalyzer (Olym-pus,
Kobe, Japan). All analytes were measured in an autoanaly-
zer (Bayer RA-XT, Tarrytown, NY, USA) using kits by the
same company (Bayer Diagnostics, Tarrytown, NY, USA).
Definitions
According to JNC-7 report [20,21], hypertension is defined
as SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg and/or use
of antihypertensive medications. BMI’s is categorized into






Age (years) 54.4 ± 10.8 53.4 ± 10.3 <0.001
Height (cm) 166.4 ± 6.3 155.6 ± 6.1 <0.001
Weight (kg) 68.6 ± 11.1 60.3 ± 10.1 <0.001
Waist circumstance (cm) 83.8 ± 9.8 81.3 ± 9.7 <0.001
BMI (kg/m2) 24.7 ± 3.5 24.9 ± 3.8 0.065
TC (mmol/L) 5.17 ± 1.04 5.29 ± 1.12 <0.001
HDL-C (mmol/L) 1.41 ± 0.42 1.41 ± 0.34 0.660
LDL-C (mmol/L) 2.88 ± 0.79 2.97 ± 0.84 <0.001
TG (mmol/L) 1.66 ± 1.66 1.61 ± 1.33 0.116
SBP (mmHg) 143.7 ± 22.6 140.2 ± 24.0 <0.001
DBP (mmHg) 83.8 ± 11.8 80.6 ± 11.5 <0.001
FBG (mmol/L) 5.95 ± 1.67 5.86 ± 1.60 0.004
Han nationality (%) 5075 (94.7%) 5899 (94.9%) 0.622
Current smoking state (%) <0.001
No 2302 (42.9%) 5188 (83.4%)
Yes 3059 (57.1%) 1030 (16.6%)
Current drinking state (%) <0.001
No 2926 (54.6%) 6035 (97.1%)
Yes 2435 (45.4%) 183 (2.9%)
Educational level <0.001
Illiterate (1) 247 (4.6%) 752 (12.1%)
Primary school (2) 1987 (37.1%) 2781 (44.7%)
Middle school (3) 2514 (46.9%) 2205 (35.5%)
High school or above (4) 613 (11.4%) 480 (7.7%)
Marital status 0.022
Married 4943 (92.3%) 5661 (91.1%)
Unmarried or widowed 415 (7.7%) 555 (8.9%)
Family income (yuan/year) 0.009
<=5000 721 (13.4%) 721 (11.6%)
5000-20000 2872 (53.6%) 3438 (55.3%)
>20000 1768 (33.0%) 2059 (33.1%)
*Data are expressed as means ± SD or n (%).
BMI: body mass index; TC: total cholesterol; HDL-C: high-density lipoprotein
cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride;
SBP: systolic blood preesure; DBP: dystolic blood preesure; FBG: fasting
blood glucose.
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BMI <30 kg/m2) and obese (BMI ≥30 kg/m2), according to
the World Health Organization’s (WHO) criteria [22]. Ab-
dominal obesity was defined as WC ≥ 88 cm for females
and WC ≥ 102 cm for males [23]. Diabetes mellitus was di-
agnosed according to the WHO criteria [24]: FPG ≥ 7.0
mmol/L (126 mg/dL) and/or being on treatment for
diabetes.
Dyslipidemia was defined according to the Third Report
of the National Cholesterol Education Program Adult
Treatment Panel III (NCEP ATP III) [24]. Borderline high
and high TC was defined as having TC levels of 5.18-6.21
mmol/L (200-239 mg/dL) and ≥6.22 mmol/L (≥240 mg/
dL), respectively. Low HDL-C was defined as having
HDL-C levels <1.04 mmol/L (<40 mg/dL). Borderline
high, high, and very high LDL-C was defined as having
LDL-C levels of 3.37-4.13mmol/L (130-159 mg/dL), 4.14-
4.91 mmol/L (160-189 mg/dL), and ≥4.92 mmol/L (≥190
mg/dL), respectively. Borderline high, high, and very high
TG was defined as having triglyceride levels of 1.70-2.25
mmol/L (150-199 mg/dL), 2.26-5.64 mmol/L (200-499
mg/dL), and ≥5.65 mmol/L (≥500 mg/dL), respectively.
Dyslipidemia was defined as having at least one of the fol-
lowing: high TC, high LDL-C, low HDL-C and high TG.
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation (SD) while categorical data was presented as
frequencies or percentages. Differences between groups
were compared using Student’s t-test (two-tailed) or χ2
test for continuous variables and categorical variables,
respectively. The percentage estimates of abnormal TC,
HDL-C, LDL-C, and TG categories were calculated by
age and gender-specific groups. χ2 test for trends was
used to analyze the significance of an increase or de-
crease in prevalence across age groups. The detailed
prevalence of dyslipidemia by selected characteristics
was also calculated. To evaluate the association between
blood lipids and risk factors, multivariate logistic regres-
sion analysis was used with abnormal serum levels of
TC, HDL-C, LDL-C and TG as dependent variables and
with demographics, anthropometrics, and lifestyles as
the independent variables. The adjusted odds ratio (OR)
was presented together with a 95% confidence interval
(95% CI). All the statistical analyses were conducted
with SPSS 17.0 statistical software package (SPSS, Inc.,
Chicago, IL, USA), and P values <0.05 were considered
to be statistically significant.
Results
Characteristics of the study population
Characteristics of the study participants enrolled in this
study, as stratified by gender, are shown in Table 1.
Among the 11956 participants, 377 were excluded duringanalysis for incomplete data. A total of 11579 participants
(5361 men and 6218 women) aged 35 years and older
were included in this study. Mean age of the subjects was
54.4 and 53.4 years for male and female, respectively. Men
had significantly lower mean values for TC and LDL-C
compared with women, however, the mean concentration
for HDL-C and TG showed no difference between men
and women. The mean level of SBP, DBP and FBG were
all significantly higher for man than women. Also, smok-
ing, drinking status and educational level were significantly
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had primary school education or below and 95% of
them had Han nationality. Marital statuses and family
income grouped by gender are also presented.
Prevalence of dyslipidemia
Table 2 shows the prevalence rates of abnormal lipid
levels by age and gender group. Of 11579 subjects,
16.4% had high TC, 13.8% had low HDL-C, 2.0% had
high LDL-C, and 1.8% had high TG concentrations. And
prevalence of lipid abnormality (including borderline
dyslipidemia and dyslipidemia) was 16.4%, 13.8%, 2.0%
and 1.8% for TC, HDL-C, LDL-C and TG, respectively.
Of these measures, 36.9% of this population had at least
one type of dyslipidemia and 64.4% had at least one type
of abnormal lipid concentration. Prevalence of border-
line high and high TC was 31.4% and 16.4%, respectively,
and the prevalence for both was significantly higher in
women than in men (P < 0.001). The age-specific preva-
lence of borderline high and high TC for both men and
women increased with age (P < 0.05). Prevalence of low
HDL-C was 13.8%. The prevalence was significantlyTable 2 Prevalence of dyslipidemia in all subjects by age and
TC mmol/L (mg/dL) HDL-C mmol/L
(mg/dL)
L
5.18-6.21 ≥6.22 <1.04 3.37-4.
(200-239) (≥240) (<40) (130-15
All (n = 11579)
Total 3638 (31.4%) 1896 (16.4%) 1599 (13.8%) 2091 (18
35-44 687 (25.0%) 226 (8.2%) 415 (15.1%) 331 (12.
45-54 1121 (31.1%) 554 (15.4%) 506 (14.1%) 666 (18.
55-64 1195 (34.3%) 762 (21.9%) 442 (12.7%) 725 (20.
≥65 635 (36.4%) 354 (20.3%) 236 (13.5%) 369 (21.
p for trend <0.001 0.025
Male (n = 5361)
Total 1659 (30.9%) 764 (14.3%) 925 (17.3%) 898 (16.
35-44 346 (28.4%) 147 (12.1%) 242 (19.9%) 188 (15.
45-54 503 (31.0%) 250 (15.4%) 288 (17.8%) 300 (18.
55-64 526 (32.2%) 252 (15.4%) 245 (15.0%) 267 (16.
≥65 284 (32.1%) 115 (13.0%) 150 (16.9%) 143 (16.
p for trend 0.028 0.008
Female (n = 6218)
Total 1979 (31.8%) 1132 (18.2%) 674 (10.8%) 1193 (19
35-44 341 (22.2%) 79 (5.2%) 173 (11.3%) 143 (9.3
45-54 618 (31.2%) 304 (15.4%) 218 (11.0%) 366 (18.
55-64 669 (36.2%) 510 (27.6%) 197 (10.7%) 458 (24.
≥65 351 (40.9%) 239 (27.8%) 86 (10.0%) 226 (26.
p for trend <0.001 0.318
Data are n (%).
TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-densityhigher in men than in women (P < 0.001), and the age-
specific prevalence decreased with age only in men (P =
0.008). The prevalence of borderline high, high, and very
high LDL-C was 18.1%, 5.6% and 2.0%, respectively. The
prevalence of borderline high, high, and very high LDL-
C was significantly higher in women than in men (P <
0.001) and the age-specific prevalence increased with
age in the group of women (P < 0.001). The prevalence
of borderline high, high, and very high TG was 13.4%,
15.5% and 1.8%, respectively. Differences between men
and women were not significant. The age-specific preva-
lence increased with age in women (P < 0.001); however,
it decreased in men (p < 0.001). Table 3 shows the age-
and gender-specific prevalence rates of high TC, low
HDL-C, high LDL-C and high TG. Women were more
likely than men to have high TC (18.2% vs. 14.3%, P <
0.001), high LDL-C (8.8% vs. 6.2%, P < 0.001) and less
likely to have low HDL-C (10.8% vs. 17.3%, P < 0.001).
The prevalence of high TC, LDL-C and TG increased
significantly with advancing age, with the highest preva-
lence being observed in the group of 55–64-year-olds
(21.9%, 11.1% and 19.4%, respectively), and then declinedgender group
DL-C mmol/L (mg/dL) TG mmol/L (mg/dL)
13 4.14-4.91 ≥4.92 1.70-2.25 2.26-5.64 ≥5.65
9) (160-189) (≥190) (150-199) (200-499) (≥500)
.1%) 653 (5.6%) 230 (2.0%) 1547 (13.4%) 1795 (15.5%) 212 (1.8%)
0%) 72 (2.6%) 23 (0.8%) 269 (9.8%) 366 (13.3%) 48 (1.7%)
5%) 169 (4.7%) 56 (1.6%) 484 (13.4%) 550 (15.3%) 74 (2.1%)
8%) 281 (8.1%) 104 (3.0%) 534 (15.3%) 609 (17.5%) 66 (1.9%)
2%) 131 (7.5%) 47 (2.7%) 260 (14.9%) 270 (15.5%) 24 (1.4%)
<0.001 <0.001
8%) 246 (4.6%) 88 (1.6%) 690 (12.9%) 818 (15.3%) 121 (2.3%)
4%) 44 (3.6%) 17 (1.4%) 155 (12.7%) 235 (19.3%) 40 (3.3%)
5%) 78 (4.8%) 19 (1.2%) 198 (12.2%) 282 (17.4%) 41 (2.5%)
3%) 81 (5.0%) 39 (2.4%) 234 (14.3%) 215 (13.1%) 32 (2.0%)
2%) 43 (4.9%) 13 (1.5%) 103 (11.6%) 86 (9.7%) 8 (0.9%)
0.089 <0.001
.2%) 407 (6.5%) 142 (2.3%) 857 (13.8%) 977 (15.7%) 91 (1.5%)
%) 28 (1.8%) 6 (0.4%) 114 (7.4%) 131 (8.5%) 8 (0.5%)
5%) 91 (4.6%) 37 (1.9%) 286 (14.5%) 268 (13.5%) 33 (1.7%)
8%) 200 (10.8%) 65 (3.5%) 300 (16.2%) 394 (21.3%) 34 (1.8%)
3%) 88 (10.2%) 34 (4.0%) 157 (18.3%) 184 (21.4%) 16 (1.9%)
<0.001 <0.001
lipoprotein cholesterol; TG: triglyceride.
Table 3 Prevalence of dyslipidemia by selected characteristics and adjusted odds ratio (95% CI) of dyslipidemia prevalence
Variables High TC (≥240 mg/dl) Low HDL-C (<40 mg/dl) High LDL-C (≥160 mg/dl)
n (%) Adjusted OR (95% CI) p values n (%) Adjusted OR (95% CI) p values n (%) adjusted OR (95% CI) p values
1896 (16.4%) 1599 (13.8%) 883 (7.6%)
Gender
Male 764 (14.3%) 1 925 (17.3%) 1 334 (6.2%) 1
Female 1132 (18.2%) 1.642 (1.431, 1.884) <0.001 674 (10.8%) 0.397 (0.347, 0.455) <0.001 549 (8.8%) 1.625 (1.344, 1.964) <0.001
Age group
35-44 226 (8.2%) 1 415 (15.1%) 1 95 (3.5%) 1
45-54 554 (15.4%) 1.849 (1.564, 2.186) <0.001 506 (14.1%) 0.894 (0.772, 1.036) 0.137 225 (6.3%) 1.646 (1.282, 2.113) <0.001
55-64 762 (21.9%) 2.643 (2.224, 3.142) <0.001 442 (12.7%) 0.767 (0.651, 0.903) 0.001 385 (11.1%) 2.884 (2.246, 3.702) <0.001
≥65 354 (20.3%) 2.355 (1.914, 2.897) <0.001 236 (13.5%) 0.811 (0.660, 0.997) 0.047 178 (10.2%) 2.582 (1.926, 3.463) <0.001
BMI (kg/m2)
Normal, <25.0 879 (13.8%) 1 615 (9.7%) 1 337 (5.3%) 1
Overweight, 25.0-29.9 824 (19.1%) 1.357 (1.210, 1.521) <0.001 767 (17.8%) 2.085 (1.846, 2.356) <0.001 431 (10.0%) 1.893 (1.613, 2.221) <0.001
Obese, ≥30.0 193 (21.5%) 1.421 (1.143, 1.767) 0.002 217 (24.1%) 3.324 (2.673, 4.134) <0.001 115 (12.8%) 2.477 (1.872, 3.278) <0.001
Waist circumstance (cm)
<102 (male)/88 (female) 1515 (15.2%) 1 1339 (13.4%) 1 683 (6.8%) 1
≥102 (male)/88 (female) 381 (23.8%) 1.130 (0.958, 1.333) 0.148 260 (16.3%) 0.921 (0.762, 1.113) 0.394 200 (12.5%) 0.937 (0.754, 1.165) 0.557
Hypertension
No 670 (11.8%) 1 755 (13.3%) 1 268 (4.7%) 1
Yes 1226 (20.7%) 1.431 (1.279, 1.600) <0.001 844 (14.3%) 0.928 (0.823, 1.046) 0.222 615 (10.4%) 1.583 (1.348, 1.859) <0.001
T2DM
No 1570 (15.1%) 1 1364 (13.1%) 1 719 (6.9%) 1
Yes 326 (27.2%) 1.570 (1.359, 1.814) <0.001 235 (19.6%) 1.509 (1.282, 1.777) <0.001 164 (13.7%) 1.465 (1.213, 1.770) <0.001
Current smoking state (%)
No 1245 (16.6%) 1 977 (13.0%) 1 596 (8.0%) 1
Yes 651 (15.9%) 1.051 (0.932, 1.186) 0.415 622 (15.2%) 1.242 (1.096, 1.408) 0.001 287 (7.0%) 1.106 (0.936, 1.306) 0.239
Current drinking state (%)
No 1421 (15.9%) 1 1360 (15.2%) 1 702 (7.8%) 1
Yes 475 (18.1%) 1.691 (1.461, 1.957) <0.001 239 (9.1%) 0.310 (0.264, 0.365) <0.001 181 (6.9%) 1.193 (0.968, 1.471) 0.098
Educational level
Illiterate 249 (24.9%) 1 129 (12.9%) 1 129 (12.9%) 1
Primary school 879 (18.4%) 0.827 (0.699, 0.978) 0.027 645 (13.5%) 0.908 (0.734, 1.122) 0.370 402 (8.4%) 0.778 (0.625, 0.970) 0.025





















Table 3 Prevalence of dyslipidemia by selected characteristics and adjusted odds ratio (95% CI) of dyslipidemia prevalence (Continued)
High school or above 162 (14.8%) 0.742 (0.584, 0.942) 0.014 169 (15.5%) 0.887 (0.677, 1.162) 0.386 77 (7.0%) 0.831 (0.603, 1.145) 0.257
Marital status
Married 1682 (15.9%) 1 1475 (13.9%) 1 782 (7.4%) 1
unmarried or widowed 212 (21.9%) 1.244 (1.043, 1.484) 0.015 124 (12.8%) 1.006 (0.813, 1.246) 0.953 101 (10.4%) 1.149 (0.906, 1.457) 0.253
Family income (yuan/year)
<=5000 229 (15.9%) 1 177 (12.3%) 1 120 (8.3%) 1
5000-20000 1012 (16.0%) 1.202 (1.019, 1.419) 0.029 845 (13.4%) 1.106 (0.920, 1.329) 0.284 478 (7.6%) 1.067 (0.856, 1.329) 0.564
>20000 655 (17.1%) 1.553 (1.299, 1.857) <0.001 577 (15.1%) 1.270 (1.043, 1.547) 0.017 285 (7.4%) 1.249 (0.983, 1.588) 0.069
Variables High TG (≥200 mg/dl) Dyslipidemia (any one kind of dyslipidemia)
n (%) Adjusted OR
(95% CI)
p values n (%) Adjusted OR
(95% CI)
p values
2007 (17.3%) 4267 (36.9%)
Gender
Male 939 (17.5%) 1 2038 (38.0%) 1
Female 1068 (17.2%) 0.955 (0.836, 1.092) 0.500 2229 (35.8%) 0.847 (0.765, 0.937) 0.001
Age group
35-44 414 (15.0%) 1 830 (30.2%) 1
45-54 624 (17.3%) 0.986 (0.854, 1.139) 0.847 1299 (36.1%) 1.183 (1.058, 1.323) 0.003
55-64 675 (19.4%) 1.026 (0.879, 1.198) 0.742 1442 (41.4%) 1.386 (1.229, 1.563) <0.001
≥65 294 (16.9%) 0.866 (0.711, 1.054) 0.151 696 (39.9%) 1.278 (1.099, 1.487) 0.001
BMI (kg/m2)
Normal, <25.0 618 (9.7%) 1 1780 (27.9%) 1
overweight, 25.0-29.9 1086 (25.2%) 2.646 (2.358, 2.970) <0.001 1983 (46.0%) 2.043 (1.872, 2.230) <0.001
Obese, ≥30.0 303 (33.7%) 3.080 (2.523, 3.761) <0.001 504 (56.1%) 2.814 (2.367, 3.347) <0.001
Waist circumstance (cm)
<102 (male)/88 (female) 1497 (15.0%) 1 3452 (34.6%) 1
≥102 (male)/88 (female) 510 (31.9%) 1.473 (1.260, 1.723) <0.001 815 (51.0%) 1.142 (0.997, 1.309) 0.056
Hypertension
No 675 (11.9%) 1 1709 (30.2%) 1
Yes 1332 (22.5%) 1.595 (1.425, 1.785) <0.001 2558 (43.2%) 1.321 (1.213, 1.439) <0.001
T2DM
No 1556 (15.0%) 1 3572 (34.4%) 1





















Table 3 Prevalence of dyslipidemia by selected characteristics and adjusted odds ratio (95% CI) of dyslipidemia prevalence (Continued)
Current smoking state (%)
No 1266 (16.9%) 1 2703 (36.1%) 1
Yes 741 (18.1%) 1.309 (1.162, 1.475) <0.001 1564 (38.2%) 1.238 (1.129, 1.358) <0.001
Current drinking state (%)
No 1536 (17.1%) 1 3328 (37.1%) 1
Yes 471 (18.0%) 1.002 (0.869, 1.154) 0.983 939 (35.9%) 0.826 (0.739, 0.922) 0.001
Educational level
Illiterate 173 (17.3%) 1 423 (42.3%) 1
Primary school 882 (18.5%) 1.130 (0.933, 1.370) 0.212 1857 (38.9%) 0.916 (0.791, 1.060) 0.239
Middle school 756 (16.0%) 1.016 (0.827, 1.248) 0.879 1583 (33.5%) 0.789 (0.675, 0.924) 0.003
High school or above 196 (17.9%) 1.101 (0.856, 1.416) 0.453 404 (37.0%) 0.853 (0.703, 1.035) 0.108
Marital status
Married 1850 (17.4%) 1 3873 (36.5%) 1
Unmarried or widowed 156 (16.1%) 0.908 (0.746, 1.105) 0.336 391 (40.3%) 1.128 (0.973, 1.307) 0.110
Family income (yuan/year)
<=5000 259 (18.0%) 1 516 (35.8%) 1
5000-20000 1072 (17.0%) 0.894 (0.760, 1.053) 0.179 2289 (36.3%) 1.114 (0.980, 1.267) 0.098
>20000 676 (17.7%) 0.988 (0.828, 1.178) 0.890 1462 (38.2%) 1.339 (1.165, 1.539) <0.001






















Figure 1 Prevalence of high TC, low HDL-C, high LDL-C and high TG in hypertensive subjects between our current study and a study
from 2007.
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TC, LDL-C and TG changed with parallelism. By contrast,
the prevalence of low HDL-C declined along with advan-
cing age, with the lowest prevalence being observed in the
55–64-year-old group (12.7%), and then increasing
thereafter.
Factors associated with dyslipidemia
Table 3 shows the prevalence of high TC, low HDL-C,
high LDL-C and high TG according to different character-
istics of the participants and multivariate logistic analyses
of factors associated with dyslipidemia. With respect to
BMI, WC, BP and FBG, the prevalence of high TC,
LDL-C and TG were closely related with obesity (adjusted
OR = 1.421, 1.143, 1.767, respectively), hypertension (ad-
justed OR = 1.431, 1.279, 1.600, respectively) and DM
(adjusted OR = 1.570, 1.359, 1.814, respectively). The
prevalence of low HDL-C was associated with obesity
and DM (adjusted OR = 3.324, 2.673, 4.134, respect-
ively), but not with hypertension. Only the prevalence
of high TG was found to increase with WC (adjusted
OR = 1.473, P < 0.001).
With regard to current smoking and alcohol con-
sumption, we observed an association between cigarette
smoking and the prevalence of low HDL-C and high
TG (adjusted OR = 1.242, 1.096, 1.408, respectively). In
addition, a significant relationship was detected be-
tween alcohol consumption and prevalence of high TC
(adjusted OR = 1.691, P < 0.001). However, the preva-
lence of low HDL-C was lower among current drinkers
(adjusted OR = 0.310, P < 0.001).
As for education, an inverse relationship was observed
between the level of education and the prevalence of
dyslipidemia, mainly for high TC. Prevalence was the
highest among illiterate individuals (24.9%) and the low-
est among middle school educated individuals (12.8%),
and then increased among the group of high schooleducated or above (14.8%). We determined a significant
association between the prevalence of high TC and mari-
tal status. Compared with married or widowed subjects,
unmarried persons had greater odds of having high TC
(P = 0.015). Family income was associated with increased
odds of having high TC and low HDL-C (P < 0.05).
We also conducted a subgroup analysis including 5919
hypertensive individuals (2892 men and 3027 women)
and found significantly increased prevalence rates of
dyslipidemia in Liaoning Province compared to the re-
sult of our past study including a total of 6,412 hyper-
tensive individuals ≥35 years (2,805 men and 3,607
women) in 2007 [25]. From the result in Figure 1, we
found that the prevalence in high TC, low HDL-C, high
LDL-C and high TG had increased since these years in
both men and women.Discussion
The prevalence of dyslipidemia is steadily rising in devel-
oping countries [26]. Dyslipidemia is one of the estab-
lished conventional risk factors for CVD in the same
category with other high-risk factors such as cigarette
smoking, diabetes, and hypertension. Remarkably, these
risk factors and their associated clinical outcomes can be
largely controlled by adopting a healthy lifestyle and
with proper medications. Therefore, management of dys-
lipidemia, and its associated risk factors is an important
public health priority. The present study reports one of
the largest population-based lipid studies ever conducted
in China, in which current epidemiological characteris-
tics of dyslipidemia in Liaoning Province were analyzed.
In addition, the present study includes 85.3% of all per-
manent residents from the randomly selected 26 rural
villages, so the study provides a very representative data
applicable to Chinese population. Our study revealed an
alarmingly high prevalence of dyslipidemia in China.
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lipid levels (including borderline dyslipidemia and dys-
lipidemia) were 47.8%, 13.8%, 25.7% and 30.7% for TC,
HDL-C, LDL-C and TG, respectively, while the total
prevalence rates of dyslipidemia were 16.4%, 13.8%, 7.6%
and 17.3% for TC, HDL-C, LDL-C and TG, respectively.
Therefore, 36.9% of China adults aged ≥35 years in this
study had at least one type of dyslipidemia, which was
higher than the Chinese National Nutrition and Health
Survey conducted in 2002 (18.6%) [13]. Further, 64.4%
had at least one type of abnormal lipid concentration,
which was higher than the results from the National
Health and Nutrition Examination Survey conducted in
2003–2006 (52.9%) [12], and the International Collab-
orative Study of Cardiovascular Disease in Asia con-
ducted in 2000-2001 (53.6%) [14]. We conclude from
our data that dyslipidemia is increasing at high rates in
these populations, and dyslipidemia needs more urgent
attention than ever before.
In hypertensive participants, the prevalence of high TC,
low HDL-C, high LDL-C and high TG in Liaoning Prov-
ince had increased significantly since 2007 in both men
and women compared with our past study [25] as pre-
sented in Figure 1. Samples in the two studies con-
ducted in 2007 and 2013 came from rural areas of
Liaoning Province and had similar geographical and
demographic characteristics. Therefore, our study pro-
vides quantitative measurements of what we believe are
the true values of this increasing trend, based on our
data analysis in this population within the same region.
An increase in dyslipidemia may contribute to other
complications of hypertension and higher mortality due
to CVD. The changing lifestyle of these areas may account
for the strikingly high prevalence of dyslipidemia. This
study also revealed the possible risk factors for each kind
of dyslipidemia by multivariate logistic regression analysis.
Gender
The OR for the total dyslipidemia was greater in males
than females, which is in accordance with most previous
studies [13,27]. However, one study indicated that the
dyslipidemia is more prevalent in females [17]. Our
study demonstrated that the prevalence of low HDL-C
was higher in men and the prevalence of high TC and
high LDL-C was higher in women, which was similar to
the result of the Chinese national nutrition and health
survey (CNHS) in 2002 [13].
Age
It is worth noting that the prevalence of high TC, LDL-
C and TG increased significantly with advancing age and
thereafter began to decline, with the highest prevalence
observed among age group 55–64, thus, all three values
changed in parallel. However, the prevalence of lowHDL-C declined at first and then increased along with
advancing age, with the lowest prevalence being ob-
served among the 55–64 age group. A similar trend of
lipid distribution was found in the Trabzon lipid study,
with highest prevalence of high TC, LDL-C and TG
among the age group 60-69 [27].
BMI, WC, BP and FBG
The relationship between dyslipidemia and the trad-
itional factors including BMI, WC, BP, and FBG are pre-
sented in our study. The prevalence of high TC, LDL-C,
TG, and low HDL-C were all closely related with BMI-
defined overweight and obesity which was in agreement
with those of previous studies [16,28,29]. Dyslipidemias
are more prevalent in abdominal obesity than normal
WC. But after adjusted for other factors, WC was an in-
dependent risk factor only for high TG. The possible
reasons may be that participants in our study have less
WC and the effect on lipid is corrected by co-existing
factors. Hypertension increased the prevalence of high
TC, LDL-C, and TG but not HDL-C which was in ac-
cordance with previous population-based study [16,29].
In addition, similar with BMI, all kinds of dyslipidemia
were positively correlated with DM in this study. The
metabolic disturbances including disturbed glucose, over-
weight/obesity and abdominal fat distribution, dyslipid-
emia, and hypertension are often concurrent and strongly
associated with subsequent development of CVD, with in-
sulin resistance being the most important common mech-
anisms [30]. Our study finds that these metabolic
disturbances showed increased prevalence in our study
compared to previous studies, indicating the epidemic
trend of CVD.
Smoking and drinking
As an independent risk factor for CHD, smoking is a
major health problem in China, with a prevalence of
57.1% in male and 16.6% in female participants in our
resent study. We also determined an association be-
tween cigarette smoking and a prevalence of low HDL-C
and high TG. In addition, a positive association was de-
tected between alcohol consumption and high TC. How-
ever, the prevalence of low HDL-C was significantly
lower among current drinkers, which was same as the
result of the Trabzon lipid study [27].
Education, marital status, family income
A general inverse relationship was observed between the
level of education and dyslipidemia. Prevalence of dys-
lipidemia was the highest among illiterate individuals
(42.3%) and declined along with increased education
level with the lowest among middle school educated in-
dividuals (33.5%), and after that it increased among the
group of high school educated or above (37.0%). This
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count mainly for the progress of CHD. The detailed asso-
ciation between marital status, family income and lipid
level was also showed in Table 3, and high family income
may lead to increased OR of having dyslipidemia.
There are some limitations in our present study. One
limitation is that the dietary factors associated with dys-
lipidemia could not be analyzed due to lack of detailed
dietary survey in our current study. Another limitation
is that our design is cross-sectional, which could only re-
flect associations between dyslipidemia and risk factors.
In conclusion, our present study provides reliable and
current epidemiological information regarding dyslipid-
emia among the adult population in Liaoning Provi-
dence, revealing very high prevalence of dyslipidemia,
and calling for an urgent attention than ever before. We
also examined various risk factors for dyslipidemia, some
of which are independent risk factors for CVD. Our re-
sults are expected to be useful to develop appropriate
community-based prevention strategies for these modifi-
able risk factors of dyslipidemia and reduce the overall
CVD morbidity and mortality.
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